Search results for "non-small cell lung cancer"

GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition

A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following initial treatment or spread to...
Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy. A new study indicates that patients with...
No More Pain with Every Breath: New Robotic Lung Cancer Technique Spares Rib Nerves

No More Pain with Every Breath: New Robotic Lung Cancer Technique Spares Rib Nerves

South Korean researchers have demonstrated the safety and effectiveness of a pioneering robotic surgical technique that...
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?

Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?

“It doesn’t end with lazertinib. Keep an eye out for the next candidate in line.”Oscotec is aggressively channeling the...

"But I've Never Smoked": The Hidden Risk Factors for Lung Cancer in Non-Smokers

While smoking remains the leading cause of lung cancer, a shifting demographic in East Asia, including South Korea, is...
‘Remarkable AI’ Finds Lung Cancer Patients Who Respond Well to Immunotherapy

‘Remarkable AI’ Finds Lung Cancer Patients Who Respond Well to Immunotherapy

A domestic study has revealed that artificial intelligence can preemptively identify lung cancer patients who can...
Languages

ENGLISH

English (US)

ASIAN

日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية